OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Detalles Bibliográficos
Autores principales: de Souza, MS, Trichavaroj, R, Schuetz, A, Chuenarom, W, Phuang-ngem, Y, Jongrakthaitae, S, Ratto-Kim, S, Nitayaphan, S, Dally, L, Rerks-Ngam, S, Tartaglia, J, Francis, D, Michael, NL, Paris, RM, Kim, JH
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767576/
http://dx.doi.org/10.1186/1742-4690-6-S3-O52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767576/
http://dx.doi.org/10.1186/1742-4690-6-S3-O52

Ejemplares similares